NMTC (NeuroOne Medical Technologies) Interest Coverage: N/A (As of Mar. 2026)


NMTC NeuroOne Medical Technologies Corp NMTC
43 GF Score
Price $3.30
GF Value $6.58
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is NeuroOne Medical Technologies Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. NeuroOne Medical Technologies's Operating Income for the three months ended in Mar. 2026 was $-2.10 Mil. NeuroOne Medical Technologies's Interest Expense for the three months ended in Mar. 2026 was $0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for NeuroOne Medical Technologies's Interest Coverage or its related term are showing as below:


NMTC's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 15.71
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


NeuroOne Medical Technologies  (NAS:NMTC) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


NeuroOne Medical Technologies Interest Coverage Related Terms


NeuroOne Medical Technologies Interest Coverage Historical Data

* Premium members only.

The historical data trend for NeuroOne Medical Technologies's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

NeuroOne Medical Technologies Interest Coverage Chart

NeuroOne Medical Technologies Annual Data
Trend Dec16 Dec17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 N/A N/A 0.00 0.00

NeuroOne Medical Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.00 N/A N/A N/A

NMTC vs CTSO, CODX, PETV: Interest Coverage Comparison

For the Medical Devices subindustry, NeuroOne Medical Technologies's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeuroOne Medical Technologies Interest Coverage vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's Interest Coverage distribution charts can be found below:

* The bar in red indicates where NeuroOne Medical Technologies's Interest Coverage falls into.


NMTC
43GF Score
NeuroOne Medical Technologies Corp NMTC
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeuroOne Medical Technologies Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NeuroOne Medical Technologies's Interest Coverage for the fiscal year that ended in Sep. 2025 is calculated as

Here, for the fiscal year that ended in Sep. 2025, NeuroOne Medical Technologies's Interest Expense was $-0.33 Mil. Its Operating Income was $-4.23 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.14 Mil.

NeuroOne Medical Technologies did not have earnings to cover the interest expense.

NeuroOne Medical Technologies's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the three months ended in Mar. 2026, NeuroOne Medical Technologies's Interest Expense was $0.00 Mil. Its Operating Income was $-2.10 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.09 Mil.

GuruFocus does not calculate NeuroOne Medical Technologies's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Is NeuroOne Medical Technologies (NMTC) Overvalued in 2026?

Based on GuruFocus' analysis, NeuroOne Medical Technologies stock appears to be undervalued. The current stock price of $3.30 is trading 49.8% below its estimated GF Value™ of $6.58. GuruFocus considers NeuroOne Medical Technologies to be Possible Value Trap.

Key valuation signals for NMTC:

  • Interest Coverage: N/A
  • GF Value™: $6.58 vs. price of $3.30 (49.8% below fair value)
  • GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the NMTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NeuroOne Medical Technologies Business Description

Address 7599 Anagram Drive, Eden Prairie, MN, USA, 55344
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
43GF Score

Get the complete analysis for NMTC

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.30
Price
$6.58
GF Value